Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)

NATerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

July 19, 2019

Study Completion Date

September 20, 2022

Conditions
Functional Mitral RegurgitationMitral RegurgitationMitral Insufficiency
Interventions
DEVICE

Edwards Cardioband System

Transcatheter mitral valve repair with the Edwards Cardioband System

DRUG

Guideline Directed Medical Therapy

GDMT Only

Trial Locations (24)

10016

NYU Langone Health, New York

10032

Columbia University Medical Center/New York Presbyterian Hospital, New York

10075

Lenox Hill Hospital - Northwell Health, New York

11576

St. Francis Hospital, Roslyn

17101

Pinnacle Health, Harrisburg

19104

Hospital of the University of Pennsylvania, Philadelphia

20010

MedStar Washington Hospital Center, Washington D.C.

22908

University of Virginia Health System, Charlottesville

28203

Sanger Heart & Vascular Institute - Atrium Health, Charlotte

30322

Emory University Hospital, Atlanta

44195

The Cleveland Clinic Foundation, Cleveland

46290

St. Vincent Heart Center, Indianapolis

48202

Henry Ford Hospital, Detroit

60611

Northwestern University, Chicago

75093

The Heart Hospital Baylor Plano, Plano

77030

The University of Texas Health Science Center at Houston, Houston

80045

University of Colorado Denver, Aurora

84107

Intermountain Medical Center, Murray

90048

Cedars-Sinai Medical Center, Los Angeles

94304

Stanford University, Palo Alto

97225

Providence Health &Services, Heart & Vascular Institute, Portland

97239

Oregon Health & Science University, Portland

02215

Beth Israel Deaconess Medical Center, Boston

07960

Morristown Medical Center, Morristown

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY